Roche Diabetes Care Canada Receives Health Canada Authorization for the Accu-Chek® Guide Link Blood Glucose Meter with Wireless Connectivity newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
News provided by
Share this article
starting in Austria, bringing more discretion and simplicity to the life of people with diabetes.
●
in the same place where they keep their diabetes data.
●
People with diabetes are given the possibility to share insulin pump data with their healthcare professionals for a more integrated and personalised approach to diabetes care.
- Picture is available at AP Images (http://www.apimages.com) -
BASEL, Switzerland, May 19, 2021 /PRNewswire/ Roche today announced the launch of the mySugr Pump Control, a new module within the mySugr app. The mySugr Pump Control is designed to enable people with diabetes to control an insulin pump directly via a smartphone: import its data, view its status, and remotely deliver a standard bolus. The mySugr Pump Control is an important building block within Roche s strategy of integrated Persona
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Search jobs 07-May-2021 Lilly collaborates with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
Lilly collaborates with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
Partners offer app compatibility with Tempo Pen
™ and Tempo Smart Button
™ to help streamline diabetes management through automated data collection for insulin dose tracking
BASINGSTOKE, 6 May 2021 – With a goal of integrating data and technology to help streamline diabetes management, Eli Lilly and Company (NYSE: LLY) has signed strategic international agreements with four companies – Dexcom, Inc., Glooko Inc., myDiabby Healthcare and Roche – to advance connected solutions and streamline care for people living with diabetes in markets outside of the United States. These companies offer unique diabetes management platforms that will be